INmune Bio’s (INMB) treatment of epidermolysis bullosa received FDA orphan designation, according to a post on the agency’s site.Don't Miss Our ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

AGLE-102 is under clinical development by Aegle Therapeutics and currently in Phase II for Epidermolysis Bullosa.

Amryt Pharma has been handed a major blow by the FDA, after the US regulator rejected its marketing application for Oleogel-S10, its drug for rare and debilitating skin disease epidermolysis ...

Hassan, who lives in Germany, has a genetic disease - junctional epidermolysis bullosa - that leaves his skin as fragile as a butterfly's wings. A piece of his skin was taken, its DNA was repaired ...

InMed has a lead drug candidate in clinical development—INM-755, a CBN-based topical dermatological cream for the treatment of epidermolysis bullosa; a second drug candidate in preclinical ...

Krystal Biotech submitted a marketing authorization application to the European Medicines Agency for dystrophic epidermolysis bullosa last year. The Agency has cancelled its oral explanation of ...

Research into new bandaging aims to ease the agony experienced by those living with genetic skin condition Epidermolysis Bullosa (EB), commonly referred to as 'butterfly skin'. Scientists at ...

The Hollywood A-lister and Emma Fogarty, who is Ireland’s longest-surviving person battling the genetic condition ...

The former Liverpool, Rangers and Scotland player fought back tears as he told the BBC that Epidermolysis bullosa was the "cruellest disease out there". He was inspired to take on the 16-hour ...